Paskowitz DM - Search Results

1

BDNF reduces the retinal toxicity of verteporfin photodynamic therapy.

Paskowitz DM, Nune G, Yasumura D, Yang H, Bhisitkul RB, Sharma S, Matthes MT, Zarbin MA, Lavail MM, Duncan JL. Paskowitz DM, et al. Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4190-6. doi: 10.1167/iovs.04-0676. Invest Ophthalmol Vis Sci. 2004. PMID: 15505074

2

Neurotrophic factors minimize the retinal toxicity of verteporfin photodynamic therapy.

Paskowitz DM, Donohue-Rolfe KM, Yang H, Yasumura D, Matthes MT, Hosseini K, Graybeal CM, Nune G, Zarbin MA, Lavail MM, Duncan JL. Paskowitz DM, et al. Invest Ophthalmol Vis Sci. 2007 Jan;48(1):430-7. doi: 10.1167/iovs.06-0690. Invest Ophthalmol Vis Sci. 2007. PMID: 17197564

3

Retinal damage caused by photodynamic therapy can be reduced using BDNF.

Duncan JL, Paskowitz DM, Nune GC, Yasumura D, Yang H, Matthes MT, Zarbin MA, LaVail MM. Duncan JL, et al. Among authors: paskowitz dm. Adv Exp Med Biol. 2006;572:297-302. doi: 10.1007/0-387-32442-9_41. Adv Exp Med Biol. 2006. PMID: 17249587 No abstract available.

4

Light and inherited retinal degeneration.

Paskowitz DM, LaVail MM, Duncan JL. Paskowitz DM, et al. Br J Ophthalmol. 2006 Aug;90(8):1060-6. doi: 10.1136/bjo.2006.097436. Epub 2006 May 17. Br J Ophthalmol. 2006. PMID: 16707518 Free PMC article. Review.

5

Rapid and stable knockdown of an endogenous gene in retinal pigment epithelium.

Paskowitz DM, Greenberg KP, Yasumura D, Grimm D, Yang H, Duncan JL, Kay MA, Lavail MM, Flannery JG, Vollrath D. Paskowitz DM, et al. Hum Gene Ther. 2007 Oct;18(10):871-80. doi: 10.1089/hum.2007.065. Hum Gene Ther. 2007. PMID: 17892416

6

Choroidal neovascularization and bevacizumab therapy in Aicardi syndrome.

Wenick AS, Paskowitz DM, Tauqir MZ, Nguyen QD. Wenick AS, et al. Among authors: paskowitz dm. Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251(3):1015-7. doi: 10.1007/s00417-012-2025-5. Epub 2012 May 1. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 22546998 No abstract available.

7

Safety, tolerability, and bioavailability of topical SAR 1118, a novel antagonist of lymphocyte function-associated antigen-1: a phase 1b study.

Paskowitz DM, Nguyen QD, Gehlbach P, Handa JT, Solomon S, Stark W, Shaikh O, Semba C, Gadek TR, Do DV. Paskowitz DM, et al. Eye (Lond). 2012 Jul;26(7):944-9. doi: 10.1038/eye.2012.68. Epub 2012 Apr 27. Eye (Lond). 2012. PMID: 22538219 Free PMC article. Clinical Trial.

8

The kinase activity of the antisigma factor SpoIIAB is required for activation as well as inhibition of transcription factor sigmaF during sporulation in Bacillus subtilis.

Garsin DA, Duncan L, Paskowitz DM, Losick R. Garsin DA, et al. Among authors: paskowitz dm. J Mol Biol. 1998 Dec 4;284(3):569-78. doi: 10.1006/jmbi.1998.2202. J Mol Biol. 1998. PMID: 9826499

9

Evidence for common sites of contact between the antisigma factor SpoIIAB and its partners SpoIIAA and the developmental transcription factor sigmaF in Bacillus subtilis.

Garsin DA, Paskowitz DM, Duncan L, Losick R. Garsin DA, et al. Among authors: paskowitz dm. J Mol Biol. 1998 Dec 4;284(3):557-68. doi: 10.1006/jmbi.1998.2201. J Mol Biol. 1998. PMID: 9826498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page